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Abstract
Background: Butyrate is the main nutrient for the colonocytes but the effect of the fraction
reaching the liver is not totally known. A decrease in tissue ATP content and increase in respiration
was previously demonstrated when livers were perfused with short-chain fatty acids (SCFA) such
as butyrate, or octanoate.
In fed rats the oxidative phosphorylation yield was determined on the whole isolated liver perfused
with butyrate in comparison with acetate and octoanoate (3 mmol/L). The rate of ATP synthesis
was determined in the steady state by monitoring the rate of ATP loss after inhibition of (i)
cytochrome oxidase (oxidative phosphorylation) with KCN (2.5 mmol/L) and (ii) glyceraldehyde 3-
phosphate dehydrogenase (glycolysis) with IAA (0.5 mmol/L). The ATP flux, estimated by 31P
Nuclear Magnetic Resonance, and the measured liver respiration allowed the ATP/O ratio to be
determined.
Results: ATP turnover was significantly lower in the presence of butyrate (0.40 ± 0.10 µmoles/
min.g, p = 0.001, n = 7) and octanoate (0.56 ± 0.10 µmoles/min.g, p = 0.01, n = 5) than in control
(1.09 ± 0.13 µmoles/min.g, n = 7), whereas perfusion with acetate induced no significant decrease
(0.76 ± 0.10 µmoles/min.g, n = 7). Mitochondrial oxygen consumption was unchanged in the
presence of acetate (1.92 ± 0.16 vs 1.86 ± 0.16 for control) and significantly increased in the
presence of butyrate (p = 0.02) and octanoate (p = 0.0004) (2.54 ± 0.18 and 3.04 ± 0.15 µmoles/
min.g, respectively). The oxidative phosphorylation yield (ATP/O ratio) calculated in the whole liver
was significantly lower with butyrate (0.07 ± 0.02, p = 0.0006) and octanoate (0.09 ± 0.02, p =
0.005) than in control (0.30 ± 0.05), whereas there was no significant change with acetate (0.20 ±
0.02).
Conclusion: Butyrate or octanoate decrease rather than increase the rate of ATP synthesis,
resulting in a decrease in the apparent ATP/O ratio. Butyrate as a nutrient has the same effect as
longer chain FA. An effect on the hepatic metabolism should be taken into account when large
quantities of SCFA are directly used or obtained during therapeutic or nutritional strategies.
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Background
We have previously reported that unlike acetate, the short-
chain fatty acid (SCFA) butyrate enhances the rate of net
ATP consumption in isolated perfused liver of rat [1].
However, the contribution of oxidative phosphorylation
remains to be demonstrated. SCFAs are physiologically
produced in the colon of mammals as a result of micro-
bial fermentation of resistant starch and other dietary fib-
ers. It has been reported in humans [2] that fermentation
of 80 g of mainly soluble fibers can theoretically yield 300
to 800 mmol SCFA and human nutritional recommenda-
tions are at least 30 g of fiber/day [3]. Three SCFA (acetate,
propionate and n-butyrate) account for 83% of all SCFAs
produced and they are distributed in a fairly constant ratio
of 60:25:15, butyrate accounting for about 13% (from 40
to 100 mmol) [4].
A part of the absorbed SCFAs plays a role in maintaining
the functional integrity of colonocytes. Butyrate is the
main substrate for the aerobic energy metabolism and a
trophic factor of the colonocytes [5,6]. Provision of
butyrate alone has been shown to increase mucosal
growth and epithelial proliferation in the intestine [7]. In
humans with intestinal bowel inflammation or colic
resection, local trophicity can be improved by irrigation
with SCFA [8] or butyrate alone [9], suggesting their ther-
apeutic interest in humans. Moreover, the properties of
butyrate on cell growth and the cell cycle are not strictly
restricted to the colonic cells, as butyrate has been used to
restore differentiated hepatocyte-specific functions in a
human liver cell line [10].
Besides this trophic effect of SCFAs, another part of them
reaches the liver via the portal vein and is metabolized. A
removal by the liver close to 100% of butyrate has been
thus evidenced in Wistar rats adapted to a high fiber diet
[11] and butyrate was also taken up by the liver at a high
rate after intracecal loads in the rat [12].
Acetate and butyrate are oxidized and propionate is a glu-
coneogenic substrate. However, even fatty acids can indi-
rectly produce a stimulation of gluconeogenesis in livers
perfused with gluconeogenic substrates, such as lactate
[13]. The liver poorly uses lactate in fed rats, but oleate
and mainly octanoate are known to reduce the threshold
of the lactate hepatic use in gluconeogenesis [14]. A high
production of acetylCoA from octanoate (which is inde-
pendent of the carnitine acyltransferase system) has been
proposed in isolated hepatocytes to explain the drastic
increase in the utilization of lactate, compared to longer
FFA [14], whereas acetate was practically ineffective in
stimulating lactate utilization. The first step in the meta-
bolic pathways of acetate and butyrate is activation in the
acyl-CoA derivatives to be used in the cell. All these ATP-
consuming steps (activation, neoglucogenesis) need to be
compensated under physiological conditions by an
increase in ATP synthesis in order to maintain an energetic
steady state in the cell. Moreover, acyl-CoA are subjected
to the mitochondrial β-oxidation that produces acetyl-
CoA and reduced cofactors (NADH+H+, FADH2). The
entry of acetyl-CoA into the Krebs cycle also generates
some reduced cofactors. The latter have to be reoxidized
by the mitochondrial respiratory chain, which consumes
oxygen [15,16]. This reoxidation induces a proton flux
occurring across the mitochondrial inner membrane that
leads in part to a coupled ATP synthesis by means of oxi-
dative phosphorylation.
Among medium-length FFA, octanoate is usually used to
investigate the effect of FFA on energy metabolism and it
has been shown to decrease the mitochondrial ATP/O
ratio, thus reflecting the oxidative phosphorylation yield
[17]. However, few studies have been devoted to butyrate
which, unlike acetate, enhances the rate of net ATP con-
sumption in perfused isolated rat liver [1].
Evaluation of the ATP/O ratio in the whole organ requires
the determination of both oxygen consumption and the
rate of ATP synthesis. The in vivo ATP turnover can be
measured by using NMR magnetization-transfer tech-
niques [18,19], although this method is controversial
[20]. From studies combining the estimation of ATP turn-
over by NMR spectroscopy and respiration by polarogra-
phy in the whole isolated rat liver, it is possible to
calculate the ATP/O ratio [21,22].
Our aim was to investigate the effect of butyrate on the
oxidative phosphorylation yield in the whole isolated rat
liver. For this purpose, the chemical inhibition of the ATP
synthesis pathways (glycolysis and oxidative phosphor-
ylation) made it possible to evaluate the contribution of
each pathway to the rate of liver ATP synthesis by moni-
toring the ATP content using 31P NMR [21].
Results
Effect of substrate on ATP content
A typical 31P NMR spectrum of an isolated rat liver per-
fused at 37°C with KHB is shown in Figure 1A. The liver
ATP content (2.60 ± 0.05 µmol/g liver ww; n = 34) deter-
mined from the β-NTP resonance area was quite stable
during the initial 30 min period of KHB perfusion in all
groups, with a slow ATP degradation (9.01 ± 0.68 nmol/
min.g ww; n = 34). This basal decline in ATP level can be
prevented by addition of glucose 30 mmol/L with or with-
out insulin [23] leading to suggest its metabolic cause and
not a loss of ATP by leakage. Because of the slow ATP deg-
radation, the ATP content was considered near the steady
state for short-lasting perfusion (<10 min). This basal ATP
consumption led to an ATP level of approximately 72 ±
3% of the initial content after a total of 100 min KHB per-BMC Physiology 2007, 7:8 http://www.biomedcentral.com/1472-6793/7/8
Page 3 of 10
(page number not for citation purposes)
Typical 31P Nuclear Magnetic Resonance spectra of an isolated rat liver Figure 1
Typical 31P Nuclear Magnetic Resonance spectra of an isolated rat liver. A: After 30-min control KHB normothermic 
perfusion. Major resonances are assigned to (a) phosphomonoesters; (b) phosphocholine; (c) intracellular inorganic phosphate 
(Pi); (d) glycerol-3-phosphoryl ethanolamine and glycerol-3-phosphorylcholine; (e) nucleoside-5'-triphosphates (γNTP) and 
diphosphates (βNTP); (f) α-NTP and α-NDP; (g) nicotinamide adenine dinucleotide; (h) uridine-5'-diphosphoglucose; (i) βNTP. 
The reference (methylene-diphosphonic acid) is not shown (18.40 ppm) (number of scans = 148). B: 20 min after a perfusion of 
butyrate 3 mmol/L, effect (from the bottom to the top) of the simultaneous addition of IAA 0.5 mmol/L (2 min) and KCN 2.5 
mmol/L (10 min) (number of scans = 60).BMC Physiology 2007, 7:8 http://www.biomedcentral.com/1472-6793/7/8
Page 4 of 10
(page number not for citation purposes)
fusion. Livers were also perfused with acetate, butyrate or
octanoate. The addition of 3 mmol/L of acetate induced a
decrease in the ATP content and led to a new steady state
of ATP content stabilized at 59 ± 4.6% after 20–30 min-
utes (p = 0.03 vs  KHB). The addition of 3 mmol/L of
butyrate or octanoate induced a more rapid decrease in
ATP content and led to a new steady state of ATP content
at a level of 42 ± 4.9% for butyrate and 43 ± 5% for
octanoate after 20–30 minutes (both p < 0.001 vs KHB).
The observed decrease in the ATP content was not reversi-
ble after removal of the substrates [1].
This result confirmed a different effect on ATP content of
two groups of fatty acids [1]: (i) acetate, which is not con-
cerned by the β-oxidation pathway, did not significantly
affect the net ATP consumption whereas the ATP content
was significantly decreased after 20–30 min perfusion,
and (ii) butyrate and octanoate, which are oxidized in the
β-oxidation pathway, induced a large decrease in ATP con-
tent due to a significant increase in the net ATP consump-
tion.
Effect of substrate on ATP turnover: calculation of ATP 
synthesis rates
KHB group (Figure 2A)
After the ATP steady state was reached, the inhibition of
both oxidative phosphorylation and glycolysis (IAA +
KCN addition) induced a drastic fall in ATP content reach-
ing zero within 2–3 min at a rate of 1.09 ± 0.13 µmole/
min.g (n = 7) (Table 1) in the whole organ. This rate was
100-fold faster than the rate of basal ATP consumption
(considered as negligible).
Fatty acid group (Figures 1B and 2B)
When the steady state of ATP content was reached in the
presence of each fatty acid (20–30 min perfusion), the
total ATP synthesis rate was calculated when IAA + KCN
were added. The values gave an ATP synthesis rates of 0.76
± 0.10, 0.40 ± 0.10 and 0.56 ± 0.10 µmole/min.g for ace-
tate (n = 7), butyrate (n = 7) and octanoate (n = 5), respec-
tively. Therefore, there was a significantly lower ATP
turnover in the presence of butyrate (p = 0.001) and
octanoate (p = 0.01) compared to the KHB group (Table
1).
O2 consumption (VO2)
During KHB perfusion (basal condition), mitochondrial
liver consumption was 1.86 ± 0.16 µmol oxygen/min.g
ww (n = 7). The addition of 3 mmol/L of each substrate
(acetate, butyrate and octanoate) induced an increase in
oxygen consumption and reached a new steady state for
mitochondrial VO2 after 15 min of perfusion (Table 1)
increasing with chain length, thus confirming previous
results [1]. Addition of IAA + KCN induced the total and
immediat inhibition of mitochondrial respiration, lead-
ing to a decrease in a few seconds in effluent oxygen to a
concentration around 24% (0.59 µmol O2/min.g ww) of
the initial concentration, thus reflecting KCN-insensitive
oxygen consumption in agreement with recent results
[24]. Moreover, it has been previously demonstrated that
only ≈30% of the mitochondrial respiration was devoted
to ATP synthesis [24,25].
Validation of the method of inhibition of ATP synthesis 
(Table 2)
When KCN was used alone, a rapid and partial decrease in
ATP signal was observed: the ATP content was not totally
decreased and remained at a stable level around 20 to
40% of the initial value. However, the total inhibition of
mitochondrial respiration in a few seconds indicated that
the ATP plateau, observed after addition of KCN alone,
probably originated from glycolysis. A subsequent addi-
Time course of liver ATP content throughout the entire pro- tocol perfusion Figure 2
Time course of liver ATP content throughout the 
entire protocol perfusion. Simultaneous inhibition of glyc-
olytic ATP synthesis by IAA (0.5 mmol/L, 2 min) and of ATP 
mitochondrial synthesis by KCN (2.5 mmol/L, 10 min) for 
two typical experiments performed in presence of (A) 
Krebs-Henseleit Buffer and (B) butyrate (3 mmol/L). The 
results are expressed as percent of ATP content, the 100% 
value being at the beginning of KHB perfusion (2.60 ± 0.05 
µmol/g liver wet weight).BMC Physiology 2007, 7:8 http://www.biomedcentral.com/1472-6793/7/8
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tion of IAA slowly induced total removal of this residual
ATP content, confirming this hypothesis.
The comparison of the ATP decline between the inhibi-
tion conditions with KCN alone or simultaneous
KCN+IAA, showed that the rate of ATP decrease was not
changed by the presence of IAA at the onset of inhibition.
At first sight, this should mean only a slight contribution
of glycolysis to ATP synthesis in the liver.
On the other hand, when glycolysis was previously inhib-
ited by IAA (0.5 mmol/L; 2 min), we observed a slight
decrease in ATP content to a new steady state reached
within 10 min. This decrease accounted for a maximum of
10% of the initial ATP content, indicating a slight contri-
bution of glycolysis to total ATP synthesis. Moreover,
there was a transient (5 min) VO2 increase (< 10 ± 2%)
which returned to baseline. The further addition of KCN
in a delay of 15 min after the addition of IAA induced an
immediate and drastic fall in ATP content (to zero) and
VO2, thereby showing that mitochondrial respiration and
ATP synthesis were totally inhibited. In this sequential
inhibition, the apparent rate of ATP decrease was at least
1.5-fold faster than that observed during simultaneous
KCN+IAA inhibition, indicating a compensatory stimula-
tion of oxidative phosphorylation after the inhibition of
glycolysis alone. Therefore the sequential inhibition was
not suitable for the purpose of our study.
Finally, in order to avoid overestimation of ATP synthesis
flux, the use of this method of inhibition to determine
ATP synthesis implies no increase in the activity of mito-
Table 1: Calculation of mitochondrial ATP synthesis yield in isolated liver perfused with Krebs-Henseleit Buffer or substrates
ATP synthesis rate VO2 ATP/O
KHB 1.09 ± 0.13 1.86 ± 0.16 0.30 ± 0.05
(n = 7) - - -
Acetate 0.76 ± 0.10 1.92 ± 0.16 0.20 ± 0.02
(n = 7) NS NS NS
Butyrate 0.40 ± 0.10* 2.54 ± 0.18* 0.07 ± 0.02**
(n = 7) p = 0.001 p = 0.02 p = 0.0006
Octanoate 0.56 ± 0.10*** 3.04 ± 0.15*** 0.09 ± 0.018***
(n = 5) p = 0.01 p = 0.0004 p = 0.005
ATP synthesis rate and mitochondrial VO2 are expressed in µmole/min.g liver ww. ATP/O = ATP (µmol ATP)/2 VO2 (µatoms oxygen). The control 
group was perfused with Krebs-Henseleit buffer (KHB); the fatty acids were perfused at 3 mmol/L. Values are given as mean ± SEM (Significant 
ANOVA and t-test).
* p < 0.03 versus acetate, ** p = 0.0006 versus acetate, *** NS versus butyrate.
Table 2: Effects of various sequences of ATP synthesis inhibition in KHB group
Sequences IAA following by KCN KCN following by IAA Simultaneous 
IAA+KCN
IAA KCN KCN IAA IAA+KCN
Residual ATP 
content (% of the 
initial value)
90% 0 20–40% 0 0
Residual 
mitochondrial 
VO2(% of the initial 
value)
1 1 0 %  ( t r a n s i e n t ) 0000
Initial rate of ATP 
hydrolysis*
ND 1.5 1.0 ND 1.0
Total inhibition of: Glycolysis only OP only OP only Glycolysis only Glycolysis and OP 
simultaneously
* arbitrary units; 1.0 corresponding to the rate of ATP decrease in simultaneous IAA+KCN sequence (1.09 ± 0.13 µmol/min.g liver wet weight). OP 
= oxidative phosphorylation.BMC Physiology 2007, 7:8 http://www.biomedcentral.com/1472-6793/7/8
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chondrial ATP-consuming systems consecutively to the
inhibitor addition. In the isolated mitochondria, it has
been demonstrated that a rapid reduction of the proton
motive force following CN- addition induced the change
of F0–F1 ATP synthase activity to ATPase activity, hydrolyz-
ing ATP originated from cytosol via the ATP/ADP translo-
case [26,27]. Hence, we performed complementary
kinetic studies of change of whole liver ATP content in
presence or in absence of carboxyatractyloside (200 µmol/
L), the specific, non competitive and irreversible inhibitor
of translocase [28], when KCN and IAA were used. There
was no significant difference of the rate of ATP decrease,
demonstrating that in response to the large KCN-induced
decrease of proton motive force, liver cytosolic ATP was
not hydrolysed in situ by mitochondria.
Yield of ATP synthesis: ATP/O ratio (Table 1)
The ATP/O ratios (µmol ATP/µatom oxygen) were calcu-
lated from the previous values of ATP synthesis rate and
mitochondrial oxygen consumption. Perfusion with
butyrate led to an ATP/O ratio significantly lower (p =
0.0006) than that of the control group and similar to
those obtained in the presence of octanoate. No signifi-
cant variation was observed in the presence of acetate
compared to control.
These results demonstrated that fatty acids entering the β-
oxidation pathway decreased the oxidative phosphoryla-
tion yield by 77% and 70% for butyrate and octanoate,
respectively, whereas acetate, which enters the TCA cycle
directly, had no significant effect.
Discussion
Butyrate is one of the SCFAs (acetate, butyrate and propi-
onate) produced by the intestinal bacterial fermentation
of unabsorbed soluble carbohydrate. After their uptake by
the colon, they are metabolized by the colonocytes with
an action on cell growth and cell cycle, while the remain-
ing fraction reaches the liver via the portal vein where it is
metabolized. Moreover, SCFAs (butyrate) are used to sup-
plement total parenteral nutrition in patients with short
bowel syndrome or intestinal malabsorption syndromes.
Besides their trophic effects on hepatocytes [10], it is of
interest to know the influence of these substrates on oxi-
dative phosphorylation since this may reflect the supply
of ATP required for the anabolic pathways. To be free of
the known reciprocal influences on SCFA on their absorp-
tion and on their liver metabolism [29,30], our study con-
cerned only the inherent effect of separate substrates.
Among medium-length FFA, octanoate is usually used to
investigate the effect of FFA on energy metabolism and it
has been shown to decrease the mitochondrial ATP/O
ratio, thus reflecting the oxidative phosphorylation yield
[17]. However, few studies have been devoted to butyrate
which, unlike acetate, enhances dramatically the rate of
net ATP consumption in perfused isolated rat liver [1].
The present work mainly sought to estimate the effects of
butyrate on the yield of in situ mitochondrial oxidative
phosphorylation in perfused rat liver. NRM spectroscopy
made it possible to monitor continuously the ATP content
and its turnover in real time in a whole organ or organism.
The in vivo ATP turnover can be measured by using NMR
magnetization-transfer techniques [18,19], although this
method is controversial [20] leading to a very large over-
estimation of ATP fluxes in the liver [18]. Indeed, its basis
is the use of exchange reactions between terminal phos-
phate of ATP and inorganic phosphate (Pi) at the level of
(i) mitochondrial ATP synthase or (ii) glycolysis (glyceral-
dehyde-3-phosphate dehydrogenase/phospho-glycerate
kinase couple); the phosphate exchange can be increased
during the NMR magnetization-transfer experiment with-
out any net ATP synthesis. Nevertheless, from studies
combining the estimation of ATP turnover by NMR spec-
troscopy and respiration by polarography in the whole
isolated rat liver, it is possible to calculate the ATP/O ratio
[21,22]. The kinetic method used here to evaluate ATP
turnover was based on the complete and rapid inhibition
of the processes involved in cellular ATP synthesis,
namely, oxidative phosphorylation (inhibited by KCN)
and glycolysis (inhibited by IAA). The rates of ATP synthe-
sis and consumption were equal at the steady state. Dur-
ing blockage of the ATP synthesis pathways, the ATP
concentration in the organ diminished on the basis of the
cellular ATP consumption rate. In fact, the transient
increase in oxygen uptake upon previous addition of IAA
during sequential inhibition (as shown in the comple-
mentary experiment) suggests that there is some degree of
adjustment to the impaired metabolic state, in the pres-
ence or absence of SCFA. Indeed, the apparent ATP syn-
thesis flux was consistently higher when oxidative
phosphorylation was inhibited after glycolysis than when
their inhibitors were added together or when KCN was
used alone (more than 50% increase). This result suggests
that when glycolysis was inhibited before oxidative phos-
phorylation, the mitochondria compensated for the loss
of glycolytic ATP. Therefore, the sequential inhibition pro-
tocol is not suitable for our purpose and both oxidative
phosphorylation and glycolysis must be simultaneously
inhibited in order to avoid compensatory and reciprocal
stimulation. Even if the IAA inhibition was not immedi-
ate, the contribution of glycolysis to ATP content and ATP
flux remained less than 10% at the onset of KCN inhibi-
tion.
The respiration rate in coupled mitochondria is a function
of several factors including the ADP supply, the proton
leak rate, the prevailing membrane potential, and the
redox potential span between the electron donors andBMC Physiology 2007, 7:8 http://www.biomedcentral.com/1472-6793/7/8
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acceptors. In addition, the activity of the respiratory com-
plexes affects the respiration rate. Nevertheless, the contri-
bution of the various components to the flux control of
mitochondrial respiration has been a matter of endless
debate for several decades. The production of acyl-CoA via
short-chain acyl-CoA synthase consumes one ATP/mole
FFA whatever the chain length. Butyryl-CoA and octanoyl-
CoA are then β-oxidized providing acetyl-CoA and
reduced cofactors. Acetyl-CoA finally enters the citric
cycle. Among various factors, the rate of respiration
depends in part on the amount of reduced cofactors
(FADH2 and NADH+H+) produced during β-oxidation
and the citric cycle.
The present work confirms that the respiration rate
increased with chain length at the concentration used,
according to the process of the β-oxidation pathway
[31,1], the lowest respiration rate being observed in the
presence of acetate. Because respiration was greatly stimu-
lated in the presence of butyrate and octanoate, an
increase in coupled ATP synthesis was expected. However,
the ATP content (resulting theoretically from both con-
sumption and synthesis) was unexpectedly decreased at
the same rate when butyrate and octanoate were added,
reaching a plateau after at least 20 minutes, as previously
demonstrated [1]. In this condition, glycolysis was proba-
bly inhibited since these fatty acids have been shown to
inhibit this pathway in isolated hepatocytes [32]. Moreo-
ver, fatty acids have been identified as potent activators of
hepatic gluconeogenesis in presence of neoglucogenic
substrates such as lactate and pyruvate [13,14]. Therefore,
we attempted to estimate in situ the flux of ATP synthesis
originating from mitochondria, counterbalancing all ATP-
consuming processes.
The ratio of synthetic flux of ATP to the mitochondrial
liver respiration allowed the phosphorylative oxidation
yield to be calculated. Butyrate or octanoate reduced the
oxidative phosphorylation rate and increased the respira-
tion rate, leading to the decrease in mitochondrial ATP/O
ratio. Octonoate and longer-chain FA have been demon-
strated to impair mitochondrial activity due to (i) an
intrinsic uncoupling of the respiratory chain (direct
effect), hence reducing ATP synthesis [17,33] and/or (ii) a
change in the proportion of electron supply to the cou-
pling site due to the increase in FADH2/NADH+H+ ratio
resulting from β-oxidation [17]. Since the respiration rate
depends partly and directly on the amount of reduced
cofactors, the latter process could explain in part the
dependence from the chain length of the decrease in ATP/
O ratio. The low values of hepatic ATP/O ratio calculated
in the control fed rats demonstrated that the in situ mito-
chondrial activity in the whole liver was slight and phe-
nomenologically near to state IV, as also observed in the
mitochondria freshly isolated from the liver of fed rats
[34]. These low ATP/O ratios were far from the P/O ratio
of 2.48 indirectly estimated in the perfused liver isolated
from 24-hr fasted rat [35] and far from the maximal phos-
phorylation capacity. In our study the addition of butyrate
as well as octanoate induced a large decrease in the yield
of phosphorylation, implying that substrate oxidation
leads to a large enthalpy supply.
Conclusion
The difference in the hepatic oxidation pathway of the
physiological substrates acetate and butyrate could
explain their different action on energy metabolism.
Butyrate is the main nutrient for the colonocytes but the
large remaining fraction reaching the liver [11] has the
same effect as longer-chain FFA. An effect on hepatic
metabolism has to be taken into account when large
quantities of SCFA are found in therapeutic purposes,
especially in long-term acarbose treatment of patients
with metabolic syndromes such as type 2 diabetes [36] or
NASH [37], thereby reducing the risk of cardiovascular
events [38]. Acarbose, an alpha-glucosidase inhibitor,
reduces postprandial plasma glucose excursions by delay-
ing the absorption of carbohydrate from the small intes-
tine. It increases (i) the amount of starch entering the
colon and (ii) butyrate production, as shown in fer-
mented samples collected in humans undergoing this
treatment [39,40]. Moreover, long-chain FFA have been
shown to play a large part in the pathogenesis of insulin
resistance in human obesity [41], in skeletal muscle and
liver [42]. The specific question of the role of butyrate in
the metabolic syndrome remains to be elucidated.
Methods
Chemicals
High-grade chemicals were purchased from Sigma Chem-
ical (St. Louis, Missouri, USA) except where otherwise
specified.
Animals and liver perfusion
Media were diluted daily from concentrated stock solu-
tions. Standard Krebs-Heinseleit buffer (KHB) was com-
posed of (in mmol/L) 120 NaCl, 4.7 KCl, 1.2 MgSO4, 25
NaHCO3, 1.2 KH2PO4-K2HPO4, 1.3 CaCl2, 0.3 Na-pyru-
vate and 2.1 Na-lactate (pH = 7.35 at 37°C). Acetate,
butyrate or octanoate were added to the KHB (3 mmol/L
for each substrate). This concentration was chosen as we
have previously demonstrated that it leads to maximal
oxygen consumption and allows the ATP content steady
state to be reached more quickly [1].
Male Wistar rats (Centre d'élevage Depré, St Doulchard,
France) weighing 80–120 g, were fed ad libitum in order to
be free of the metabolic effects of the endogenous FA due
to lipolysis observed in fasting conditions. The diet con-
tained 76.55% cereals and the daily caloric supply wasBMC Physiology 2007, 7:8 http://www.biomedcentral.com/1472-6793/7/8
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(kcal/kg) 4.05% lipids, 3.95% fiber, 18.70% protein,
5.35% minerals and 55.85% carbohydrates [1]. Lipid sup-
ply consisted of a mixture of saturated and unsaturated
long-chain fatty acids (C16 and C18). Rats were anesthe-
tized by intraperitoneal injection of pentobarbital sodium
(50 mg/kg of rat), and the technique of liver antegrade
perfusion through the portal vein has been described pre-
viously [43]. Briefly, the liver (4–6 g) was perfused in nor-
mothermic and well oxygenated conditions with KHB at
37°C regulated by a thermostatic bath. The perfused liver
was then excised from the rat abdomen and transferred to
a 20 mm-diameter NMR cell. All experiments were carried
out after a 20–30 min metabolic equilibration period in
KHB.
The perfusate was pumped through a Silastic© home-made
oxygenator, gassed with 95% O2 and 5% CO2 (1 bar pres-
sure). Perfusion flow was kept constant (5 ml/min.g liver
wet weight) and was sufficient to ensure good oxygena-
tion of the liver. Perfusate temperature and pH were mon-
itored both before entering and after leaving the liver by
continuous-flow pH electrodes and temperature elec-
trodes.
Determination of ATP/O ratio
In order to suppress cytosolic and ATP mitochondrial pro-
duction, perfusion was performed using both IAA (0.5
mmol/L) to inhibit glyceraldehyde 3-phosphate dehydro-
genase (glycolysis) and KCN (2.5 mmol/L) to inhibit
cytochrome oxidase (oxidative phosphorylation). In com-
plementary experiments we showed that the addition of
0.5 mmol/L IAA for two minutes is sufficient to prevent
glycolysis totally and irreversibly, without preventing the
ATP mitochondrial metabolism (data not shown).
Three groups of animals were used:
(i) NMR measurement group: A first group was submitted
to continuous NMR measurements in order to study the
kinetic of the ATP content: the sequence was as follows: (i)
initial KHB metabolic equilibration period (20–30 min),
(ii) addition (or not = control) of substrate (3 mmol/L,
40–60 min) and (iii) in presence (or not = control) of sub-
strate, addition of both IAA (0.5 mmol/L, 2 min) and
KCN (2.5 mmol/L, 10 min), followed by (iv) a KHB rinse
phase.
(ii) Respiratory measurement group: A second group was
devoted to respiratory measurements through a similar
sequence.
(iii) Both NMR and respiratory measurement group: A
third group corresponded to experiments with sequential
NMR and respiratory measurements (requiring removal
of NMR cell from magnet).
Validation of the method of ATP synthesis inhibition
Complementary experiments were performed in order to
evaluate the effect of the inhibition of the glycolytic path-
way on mitochondrial ATP synthesis. For this purpose,
three groups of livers were used:
First group: only KCN (2.5 mmol/L, 40 min) was added
to inhibit oxidative phosphorylation.
Second group: a sequential inhibition was performed
with KCN added firstly (2.5 mmol/L, 40 min) and fol-
lowed by a delayed (15 min after the onset of KCN addi-
tion) IAA addition (0.5 mmol/L, 2 min).
Third group: a sequential inhibition was performed with
IAA (0.5 mmol/L, 2 min) added firstly and followed by a
delayed (15 min) KCN addition (2.5 mmol/L).
The study complied with the Guide for the Care and Use
of Laboratory Animals, U.S. Department of Health and
Human Services, N.I.H. Publication No. 85-23, revised
(1985).
31P NMR measurements
NMR measurements on isolated liver were performed on
a Bruker DPX-400 wide-bore spectrometer operating at
9.4 T. 31P and 13C NMR spectra were recorded at 161.9
and 100.6 MHz respectively, with a 31P/13C double-tuned
20 mm probe. The magnetic field was adjusted to the
water proton signal. 31P-NMR spectra were obtained with-
out proton decoupling every 1 min and 30 seconds (148
free induction decays, FIDs) throughout the sequence pro-
tocol, except during inhibitor addition times, every 20 sec-
onds (40 FIDs) in order to increase the determination
accuracy. Radiofrequency pulses of 25 µs duration (70°
flip angle) with 0.2 s acquisition time, 0.4 s total recycling
time, 10000 Hz spectral width and 4 K data points were
used for data acquisition. A Lorentzian line broadening of
15 Hz was applied prior to Fourier transformation for 31P
NMR spectra. An external reference of 13 µmoles methyl-
ene diphosphonic acid (MDPA set at 18.40 ppm) was
used to quantify the phosphorylated metabolites.
Hepatic ATP levels were estimated from peak areas and
expressed as a percentage of the initial value obtained at
the beginning of the 30-min equilibration period in KHB.
Evaluation of ATP turnover
When the steady state of the ATP content was reached after
the addition of substrate, the addition of "IAA+KCN"
allowed the ATP turnover to be determined. At the onset
of inhibition, the ATP synthesis velocity corresponds to
the initial ATP degradation velocity according to: Vs(t = 0) =
d [ATP](t = 0)/dt with ATP = A.exp(-kt), where k is the con-
stant time and A the liver content at the onset of the addi-BMC Physiology 2007, 7:8 http://www.biomedcentral.com/1472-6793/7/8
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tion of IAA+KCN. Vs was expressed in µmoles ATP/min.g
wet weight (ww).
Oxygen consumption measurements
Isolated perfused livers were placed in an NMR cell similar
to that used for the NMR experiments. The total oxygen
consumption of liver was continuously monitored using
O2 Clark electrodes, placed in the perfusion circuit just
before and after the liver, using an oxygenmeter model
781 (Strathkelvin Instrument, Glasgow, Scotland). Oxy-
gen consumption (µmol O2/min.g liver ww) VO2 = (per-
fusate O2 content - effluent O2 content) × liver flow rate
(ml/mn.g ww) was calculated, where perfusate O2 content
was expressed in µmol/ml. The mitochondrial respiration
component of tissue respiration was calculated by sub-
tracting the KCN-insensitive oxygen consumption from
the total O2 consumption.
Statistics
All results were expressed as means ± SEM. Statistical anal-
ysis was performed with Microsoft® Excel 2000 (Microsoft
Corporation). One-way analysis of variance (ANOVA)
was performed for all data analyses. A t test was performed
following the analysis of variance (p value lower than
0.05 was considered to be significant).
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